These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 31952546

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
    Liu N, Li P, Zang S, Liu Q, Ma D, Sun X, Ji C.
    PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
    [Abstract] [Full Text] [Related]

  • 23. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X, Zhao H, Li Y, Fan J, Sun Y, Wang S, Wang Z, Song P, Ju D.
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    Lin TY, Chen KC, Liu HJ, Liu AJ, Wang KL, Shih CM.
    PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340
    [Abstract] [Full Text] [Related]

  • 25. BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin.
    Xu X, Zhang X, Liu Y, Yang L, Huang S, Lu L, Wang S, Guo Q, Zhao L.
    Oncotarget; 2016 Apr 26; 7(17):24436-54. PubMed ID: 27027438
    [Abstract] [Full Text] [Related]

  • 26. Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2V617F cells.
    Zhou J, Guo C, Wu H, Li B, Zhou LL, Liang AB, Fu JF.
    BMC Cancer; 2021 Nov 13; 21(1):1213. PubMed ID: 34773997
    [Abstract] [Full Text] [Related]

  • 27. Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells.
    Al-Rawashde FA, Wan Taib WR, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN.
    Asian Pac J Cancer Prev; 2021 Dec 01; 22(12):3959-3965. PubMed ID: 34967577
    [Abstract] [Full Text] [Related]

  • 28. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
    Hekmatshoar Y, Ozkan T, Altinok Gunes B, Bozkurt S, Karadag A, Karabay AZ, Sunguroglu A.
    Cell Mol Biol (Noisy-le-grand); 2018 May 15; 64(6):23-30. PubMed ID: 29808796
    [Abstract] [Full Text] [Related]

  • 29. Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia.
    Kayabasi C, Okcanoglu TB, Yelken BO, Asik A, Susluer SY, Avci CB, Saydam G, Gunduz C.
    Gene; 2017 Dec 30; 637():173-180. PubMed ID: 28942039
    [Abstract] [Full Text] [Related]

  • 30. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
    Liu YX, Wang L, Liu WJ, Zhang HT, Xue JH, Zhang ZW, Gao CJ.
    J Hematol Oncol; 2016 Aug 12; 9(1):69. PubMed ID: 27516205
    [Abstract] [Full Text] [Related]

  • 31. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis.
    Chen X, Chen Y, Zhang M, Cheng H, Mai H, Yi M, Xu H, Yuan X, Liu S, Wen F.
    Cell Death Dis; 2022 Jan 28; 13(1):92. PubMed ID: 35091542
    [Abstract] [Full Text] [Related]

  • 32. MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
    Wong SM, Liu FH, Lee YL, Huang HM.
    PLoS One; 2016 Jan 28; 11(1):e0148093. PubMed ID: 26815740
    [Abstract] [Full Text] [Related]

  • 33. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA, Jusoh SA, Yong AC, Asan JM, Hassan R, Johan MF.
    Asian Pac J Cancer Prev; 2014 Jan 28; 15(11):4555-61. PubMed ID: 24969884
    [Abstract] [Full Text] [Related]

  • 34. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
    Lan X, Zhao C, Chen X, Zhang P, Zang D, Wu J, Chen J, Long H, Yang L, Huang H, Carter BZ, Wang X, Shi X, Liu J.
    J Hematol Oncol; 2016 Nov 25; 9(1):129. PubMed ID: 27884201
    [Abstract] [Full Text] [Related]

  • 35. Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia.
    Yin L, Xu J, Wu W, Niu M, Li Z, Zhu F, Xu K.
    Hematology; 2023 Dec 25; 28(1):2224625. PubMed ID: 37345979
    [Abstract] [Full Text] [Related]

  • 36. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
    Nie ZY, Liu XJ, Zhan Y, Liu MH, Zhang XY, Li ZY, Lu YQ, Luo JM, Yang L.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30962263
    [Abstract] [Full Text] [Related]

  • 37. Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance.
    Soltani I, Douzi K, Gharbi H, Benhassine I, Teber M, Amouri H, Ben Hadj Othman H, Farrah A, Ben Lakhel R, Abbes S, Menif S.
    Hematology; 2017 May 30; 22(4):201-207. PubMed ID: 27825294
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy.
    Li YL, Tang JM, Chen XY, Luo B, Liang GH, Qu Q, Lu ZY.
    Hum Cell; 2020 Jul 30; 33(3):610-618. PubMed ID: 32342278
    [Abstract] [Full Text] [Related]

  • 39. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T, Fu Y, Wang S, Xu M, Yin X, Zhou M, Wang X, Chen C.
    Biomed Pharmacother; 2019 Nov 30; 119():109413. PubMed ID: 31518872
    [Abstract] [Full Text] [Related]

  • 40. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
    Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Raanani P, Shpilberg O, Granot G.
    Cancer Lett; 2015 May 01; 360(2):245-56. PubMed ID: 25697481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.